The affordability of INNOVO at €399 is something that comes up often with our customers quite often. However, the deceptively ‘affordable’ and routine purchasing of pads as part of your weekly grocery shop might seem like a sensible way of managing leaks, but what are they really costing you?
We conducted a study that found that people dealing with bladder weakness in the UK spend an average of €5001 per year on pads, and this cost could be much higher if you experience heavier leaks. When you think about the cost over a lifetime of pad use, that’s a hefty price to pay, especially when pads only help mask, rather than solve the problem.
How much does INNOVO cost?
At €399, the INNOVO may seem pricey from the outset, but the cost is actually LESS than you’d spend on pads in just one year, AND it actually solves the problem.
Don’t let anything get in the way of solving bladder weakness! INNOVO’s non-invasive, clinically proven treatment can get you back doing all the things you used to love doing. The unisex garment is suitable for Women & Men, and treats Stress, Urge and Mixed Incontinence.
What is INNOVO and how can it help me?
INNOVO is a clinically proven, truly non-invasive and long-lasting solution to urinary incontinence. Easy to use and comfortable to wear, INNOVO helps you safely and effortlessly strengthen and re-educate the entire network of pelvic floor muscles through gentle muscle stimulation.
Using INNOVO for just 30 minutes a day/five days a week over 12 weeks has been proven to treat bladder weakness – delivering results in as little as four weeks2.
INNOVO treats Stress, Urge & Mixed Incontinence in both women and men of all ages, and is the only non-invasive pelvic floor exerciser that targets the root cause of the problem. Use INNOVO's Stress Incontinence programme which will focus on delivering muscle strengthening stimulations to the entire network of pelvic floor muscles.
A clinical study found that:
- 80% of users saw a significant reduction in leaks after just 4 weeks2
- 87% of users were defined as either dry or almost dry after 12 weeks3
- 90% of users would recommend the therapy to others4
- TEFEN Research Study, 2015
- Soeder S, et al, A randomised, controlled, double-blind, clinical study to compare two neuromuscular stimulator devices in female stress urinary incontinence: Effects on symptoms and quality of life. IUGA Conference 2018
- R. Dmochowski – Novel external electrical muscle stimulation device for the treatment of female stress urinary incontinence: randomized controlled noninferiority trial versus intravaginal electrical stimulation. ICS Conference 2018
- Observational study on the treatment of stress urinary incontinence with Innovotherapy, April 2014